The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wagner-Ballon, O.
Right arrow Articles by Giraudier, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wagner-Ballon, O.
Right arrow Articles by Giraudier, S.
The Journal of Immunology, 2006, 176: 6425-6433.
Copyright © 2006 by The American Association of Immunologists

Monocyte/Macrophage Dysfunctions Do Not Impair the Promotion of Myelofibrosis by High Levels of Thrombopoietin1

Orianne Wagner-Ballon*,{dagger}, Hédia Chagraoui2,*, Eric Prina2,{ddagger}, Micheline Tulliez§, Geneviève Milon{ddagger}, Hana Raslova*, Jean-Luc Villeval*, William Vainchenker* and Stéphane Giraudier3,*,{dagger}

* Institut National de la Sante et de la Recherche Medicale (INSERM) U790, Pavillon de Recherche 1, Institut Gustave Roussy, Villejuif, France; {dagger} Laboratoire d’Hématologie, Hôpital Henri Mondor, Créteil, France; {ddagger} Unité Immunophysiologie et Parasitisme Intracellulaire, Institut Pasteur, Paris, France; and § Laboratoire d’Anatomopathologie, Hôpital Cochin, Paris, France

Several lines of evidence indicate that the megakaryocyte/platelet lineage is crucial in myelofibrosis induction. The demonstration that NOD/SCID mice with functionally deficient monocytes do not develop fibrotic changes when exposed to thrombopoietin (TPO) also suggests an important role for monocyte/macrophages. However, in this animal model, the development of myelofibrosis is dependent on the level of TPO. This study was conducted to investigate whether NOD/SCID mice exposed to high TPO levels mediated by a retroviral vector would be refractory to the development of bone marrow fibrosis. We show that TPO and TGF-beta1 in plasma from NOD/SCID and SCID mice engrafted with TPO-overexpressing hemopoietic cells reach levels similar to the ones reached in immunocompetent mice, and all animals develop a myeloproliferative disease associated with a dense myelofibrosis at 8 wk posttransplantation. Monocytes in NOD/SCID mice are functionally deficient to secrete cytokines such as IL-1{alpha} in response to stimuli, even under TPO expression. Surprisingly, the plasma of these mice displays high levels of IL-{alpha}, which was demonstrated to originate from platelets. Together, these data suggest that completely functional monocytes are not required to develop myelofibrosis and that platelets are able, under TPO stimulation, to synthesize inflammatory cytokines, which may be involved in the pathogenesis of myelofibrosis and osteosclerosis.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. Arita, Y. Ami, T. Wakita, and H. Shimizu
Cooperative Effect of the Attenuation Determinants Derived from Poliovirus Sabin 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model
J. Virol., February 15, 2008; 82(4): 1787 - 1797.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. E. Brown, R. P. Vishwanath, B. Aguilar, R. Starr, J. Najbauer, K. S. Aboody, and M. C. Jensen
Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells
J. Immunol., September 1, 2007; 179(5): 3332 - 3341.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Wagner-Ballon, D. F. Pisani, T. Gastinne, M. Tulliez, R. Chaligne, C. Lacout, F. Aurade, J.-L. Villeval, P. Gonin, W. Vainchenker, et al.
Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice
Blood, July 1, 2007; 110(1): 345 - 353.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.